Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Brachytherapy ; 16(3): 490-496, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28185762

RESUMO

PURPOSE: To report the biochemical control rate and clinical outcomes with real-time inverse planning (inverse optimization prostate seed implant [IO-PSI]) for favorable-risk (FR) and intermediate-risk (IR) prostate adenocarcinoma in a community practice setting. This analysis is an extended followup of our initial report, with favorable early biochemical control rate (biochemical nonevidence of disease) of 97% at 4 years. METHODS AND MATERIALS: Three hundred fifty-seven evaluable patients with FR and IR prostate cancer underwent real-time IO-PSI (iodine-125/145 Gy or palladium-103/120 Gy) between 2001 and 2013. RESULTS: With a median followup of 54 months (range, 24-110 months), the absolute biochemical failure free survival of disease was 96%. The 8-year actuarial probability of prostate-specific antigen failure-free survival for FR and IR cohorts was 92.4% and 87%, respectively. Late genitourinary and gastrointestinal toxicity remained low. Late Grade 2 and Grade 3 genitourinary toxicity was 19% and 1%, respectively. Late Grade 2 and 3 rectal bleeding rates were 1% and 0%, respectively. No difference in biochemical control was observed with preimplant short course androgen deprivation or between Gleason score 3 + 4 vs. 4 + 3 patients. No dosimetric parameter was predictive of biochemical failure. Patients with FR had a significantly decreased risk of failure (hazard ratio = 0.26; 95% confidence interval = 0.09-0.78; p = 0.02) compared with those with IR. Patients with a prostate-specific antigen nadir >0.4 ng/mL had an increased risk of failure (hazard ratio = 1.37; 95% confidence interval = 1.27-1.47; p < 0.0001). CONCLUSIONS: Our initial biochemical and clinical outcomes using real-time IO-PSI persisted with extended followup and support our original hypothesis for use of a reduced number of sources, needles, and total activity, suggesting that with IO, less is more.


Assuntos
Adenocarcinoma/terapia , Braquiterapia/métodos , Radioisótopos do Iodo/uso terapêutico , Paládio/uso terapêutico , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/terapia , Radioisótopos/uso terapêutico , Adenocarcinoma/sangue , Adenocarcinoma/patologia , Idoso , Antagonistas de Androgênios/uso terapêutico , Braquiterapia/efeitos adversos , Intervalo Livre de Doença , Seguimentos , Humanos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Gradação de Tumores , Prostatectomia , Neoplasias da Próstata/sangue , Neoplasias da Próstata/patologia , Dosagem Radioterapêutica , Fatores de Risco
2.
Urology ; 48(6): 953-6, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8973688

RESUMO

A 37-year-old chronic schizophrenic man underwent penile replantation after complete autoamputation using a kitchen knife. We report the first case of using medicinal leeches to salvage a penile replant after the development of postoperative venous congestion.


Assuntos
Amputação Traumática/terapia , Sanguessugas , Pênis/lesões , Reimplante , Adulto , Animais , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA